Reports for NATCO PHARMA (CANADA) INC

Company Name
NATCO PHARMA (CANADA) INC

Shortage reports

Actual shortage:

30 (61%)

Anticipated shortage:

0 (0%)

Avoided shortage:

0 (0%)

Resolved:

19 (39%)

49

Discontinuation Reports

To be discontinued:

0

Discontinued:

0

Reversed:

0

0

1 (2%)

9 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-QUETIAPINE 150MG TABLET Actual shortage 2024-04-29 2025-03-03 226594
NAT-QUETIAPINE 200MG TABLET Resolved 2019-04-17 2022-07-01 81903
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-04 2025-04-05 254185
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-04-04 2025-04-05 254190
NAT-ZOLMITRIPTAN 2.5MG TABLET Actual shortage 2024-07-29 2024-07-30 233895
NATCO-CITALOPRAM 10MG TABLET Resolved 2024-11-11 2024-11-12 242457
NATCO-CITALOPRAM 10MG TABLET Resolved 2024-11-11 2024-11-12 242454

Showing 41 to 49 of 49

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0